1. Home
  2. ACET vs VRA Comparison

ACET vs VRA Comparison

Compare ACET & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$0.54

Market Cap

93.5M

Sector

Health Care

ML Signal

HOLD

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$2.21

Market Cap

60.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACET
VRA
Founded
1947
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
93.5M
60.6M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
ACET
VRA
Price
$0.54
$2.21
Analyst Decision
Buy
Buy
Analyst Count
4
3
Target Price
$8.50
$4.00
AVG Volume (30 Days)
1.9M
1.8M
Earning Date
11-05-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$332,526,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$1.71
52 Week High
$1.12
$5.79

Technical Indicators

Market Signals
Indicator
ACET
VRA
Relative Strength Index (RSI) 33.71 41.52
Support Level $0.53 $2.52
Resistance Level $0.57 $2.99
Average True Range (ATR) 0.05 0.32
MACD 0.00 -0.07
Stochastic Oscillator 5.35 1.63

Price Performance

Historical Comparison
ACET
VRA

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

Share on Social Networks: